Two papers published in the January issue of Nature Medicine indicate that HDACIs increase the expression of the death-receptor ligand TRAIL in cancer ... show that no apoptosis was evident ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

A promising government-funded cancer trial is back in motion after budgetary and workforce cuts imposed by the Trump administration threatened to derail its progress.

Company’s presentations highlight the power of mitochondrial medicine and protein homeostasis technologies to address ...

There is therefore an urgent need for the development and testing of novel agents targeting pathways thought to be involved in the pathogenesis of breast cancer. Aberrant activation of the Ras/Raf ...

As part of this month's special focus on apoptosis, two researchers in the field discuss their role in the development of therapeutic strategies to target apoptosis. David Huang, MBBS, MRCP (UK ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

City of Hope's DINOMITE trial has a primary goal of determining the side effect profile and most effective dose of papaverine when given with radiation therapy to patients with rectal cancer that ...